Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 1

Conditions

Stomach Neoplasms 14Prostatic Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Pancreatic Neoplasms 10Endometrial Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Lung Neoplasms 7Colonic Neoplasms 7Neoplasm Metastasis 6Carcinoma, Hepatocellular 6Oropharyngeal Neoplasms 5Multiple Myeloma 5Mouth Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Sarcoma 4Recurrence 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Esophageal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Gastrointestinal Stromal Tumors 3

Interventions

Oxaliplatin 180Capecitabine 173Fluorouracil 154Leucovorin 107Radiotherapy 106Irinotecan 93Bevacizumab 69Surgical Procedures, Operative 49Cetuximab 39Drug Therapy 38Radiation 35Neoadjuvant Therapy 33Chemoradiotherapy 29Folfox protocol 28XELOX 22Magnetic Resonance Spectroscopy 21Chemotherapy, Adjuvant 21Radiotherapy, Intensity-Modulated 19Surveys and Questionnaires 17Proctectomy 16Biopsy 16Early Intervention, Educational 14trifluridine tipiracil drug combination 12Panitumumab 12Floxuridine 12tislelizumab 11regorafenib 11Nivolumab 11Laparoscopy 11Celecoxib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Rectal Neoplasms × Observation × Clear all
NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Recruiting
120 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Emory University

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02113384 2021-07-28

LARC-EX

Oslo University Hospital

Active not recruiting
231 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Rectal Neoplasms

NCT02052921 2020-05-11

Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy

Instituto do Cancer do Estado de São Paulo

Phase NA Terminated
13 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡